Table 1.

Baseline data characteristics

Age, yr, median/IQR/min/max	58/23/15/92
Gender, n, M/F	116/93
Race, n, white/black/other	49/158/2
Length of treatment, mo, median/IQR/min/max	131/143/22/277
Hgb, g/dl, mean ± SD	11.7 ± 1.6
Epo dose 1000 U/wk, median/IQR/min/max	9/18/0/90
Ferr, ng/ml, median/IQR/min/max	612/582/2/2000
TSat, %, mean ± SD	27.2 ± 13.4
Kt/V, mean ± SD	1.43 ± 0.25
Alb, g/dl, mean ± SD	3.8 ± 0.3
Intact PTH, pg/ml, median/IQR/min/max	240/368/5/2000
Missing data proportion, %
Hgb	1.9
Ferr	7.9
TSat	4.4
Kt/V	7.1
Alb	2.3
PTH	9.3
Number of repeated measures, median/IQR/min/max
Hgb	48/49/8/2
Ferr	9/11/2/23
TSat	29/33/4/67
Kt/V	30/33/4/73
Alb	31/34/5/67
PTH	9/10/1/25

IQR, interquartile range.